These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


347 related items for PubMed ID: 10565933

  • 1. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.
    Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF.
    J Clin Microbiol; 1999 Dec; 37(12):4065-70. PubMed ID: 10565933
    [Abstract] [Full Text] [Related]

  • 2. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES, Sanders CC, Thomson KS.
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [Abstract] [Full Text] [Related]

  • 3. Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from 1998-2002.
    Dandekar PK, Barrett NL, Nightingale CH, Nicolau DP.
    Conn Med; 2003 Mar; 67(3):149-52. PubMed ID: 12687789
    [Abstract] [Full Text] [Related]

  • 4. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
    Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE, Tenover FC.
    J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
    [Abstract] [Full Text] [Related]

  • 5. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Aug; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
    Jan IS, Hsueh PR, Teng LJ, Ho SW, Luh KT.
    J Formos Med Assoc; 1998 Oct; 97(10):661-6. PubMed ID: 9830274
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S, Gaind R, Ranjan R, Deb M.
    J Infect Dev Ctries; 2009 Nov 21; 4(1):24-9. PubMed ID: 20130375
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.
    Queenan AM, Foleno B, Gownley C, Wira E, Bush K.
    J Clin Microbiol; 2004 Jan 21; 42(1):269-75. PubMed ID: 14715764
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 21; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 12. AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India.
    Gupta V, Kumarasamy K, Gulati N, Garg R, Krishnan P, Chander J.
    Indian J Med Res; 2012 Aug 21; 136(2):237-41. PubMed ID: 22960890
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S, Altanlar N.
    Mikrobiyol Bul; 2012 Jul 21; 46(3):375-85. PubMed ID: 22951650
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M, Piekarska K, Gierczyński R.
    Med Dosw Mikrobiol; 2012 Jul 21; 64(4):285-95. PubMed ID: 23484420
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.